A detailed history of Turning Point Benefit Group, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 2 shares of LMAT stock, worth $176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$176
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$79.77 - $100.33 $159 - $200
2 New
2 $173,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $1.94B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Turning Point Benefit Group, Inc. Portfolio

Follow Turning Point Benefit Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Turning Point Benefit Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Turning Point Benefit Group, Inc. with notifications on news.